GC Genome Corporation (KOSDAQ:340450)
South Korea flag South Korea · Delayed Price · Currency is KRW
8,230.00
-20.00 (-0.24%)
At close: Feb 27, 2026

GC Genome Ratios and Metrics

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Feb '26 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Debt / Equity Ratio
0.060.140.470.400.740.66
Debt / EBITDA Ratio
1.032.353.18--12.64
Debt / FCF Ratio
10.2894.54----
Net Debt / Equity Ratio
-0.50-0.060.13-0.26-0.61-0.91
Net Debt / EBITDA Ratio
-9.10-0.930.8416.39224.25-17.42
Net Debt / FCF Ratio
-90.68-37.60-0.771.253.969.75
Asset Turnover
-0.620.600.530.440.49
Inventory Turnover
-11.9611.5614.85--
Quick Ratio
8.163.741.002.136.2612.49
Current Ratio
8.574.271.122.326.4212.64
Return on Equity (ROE)
--4.32%-2.13%-16.52%1.56%-0.02%
Return on Assets (ROA)
--1.85%0.22%-4.43%-3.13%-0.01%
Return on Invested Capital (ROIC)
3.06%-4.15%0.67%-24.07%-34.01%-0.06%
Return on Capital Employed (ROCE)
1.40%-3.30%0.50%-8.40%-5.60%0.00%
Buyback Yield / Dilution
-12.73%0.66%-13.53%-0.97%10.25%-90.88%
Source: S&P Global Market Intelligence. Standard template. Financial Sources.